Company / Total Assets
Cogent Biosciences, Inc. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$937.6M
FY2025
5-year range
$232.1M / $937.6M
FY2021-FY2025
Trend
+185.9%
vs FY2024
Sector context
#86 of 214
Health Care
What the data says
At $938M, Cogent Biosciences, Inc.'s total assets ranks #86 of 214 in the Health Care sector. Total Assets has increased for 4 consecutive years, from $232M in FY2021 to $938M in FY2025.
Based on SEC 10-K filings.
$938M in FY2025 with a 5-year CAGR of +30.2%.
Improved from $313M to $938M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +46.1%
- 5-Year CAGR
- +30.2%
- 10-Year CAGR
- -
Sector benchmark
#86 of 214 in Health CareTop 40% of 214This company $937.6M Sector average $7.5B
▼
-87.4% below sector average
Key checks
Key Insights
- Cogent Biosciences, Inc.'s total assets has grown for 4 consecutive years.
- 5-year CAGR of +30.2%, indicating consistent growth.
- In FY2025, total assets increased 185.9% year-over-year.
- Ranks #86 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $937.6M | +185.9% |
| FY2024 | $327.9M | +4.6% |
| FY2023 | $313.4M | +4.2% |
| FY2022 | $300.8M | +29.6% |
| FY2021 | $232.1M | -7.5% |
| FY2020 | $250.9M | +407.7% |
| FY2019 | $49.4M | -42.5% |
| FY2018 | $85.9M | +75.0% |
| FY2017 | $49.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026